drugset / Trial / NCT00004313
Phase III Randomized, Double-Blind, Placebo-Controlled Study of Dehydroepiandrosterone Replacement for Primary Adrenal Insufficiency
Phase 3
Completed
40 enrolled
National Center for Research Resources (NCRR)
University of California, Los Angeles · collab
RandomizedDouble-blindTreatment
Summary
OBJECTIVES: I. Determine the efficacy of dehydroepiandrosterone (DHEA), an androgen replacement hormone, for patients with primary adrenal insufficiency (Addison's disease).
Timeline
- Start
- 1995-08
- Primary completion
- —
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Dehydroepiandrosterone | Other / unclassified | — | — |